Defined Microenvironments Trigger In Vitro Gastrulation in Human Pluripotent Stem Cells.


Journal

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
ISSN: 2198-3844
Titre abrégé: Adv Sci (Weinh)
Pays: Germany
ID NLM: 101664569

Informations de publication

Date de publication:
02 2023
Historique:
revised: 19 09 2022
received: 22 06 2022
pubmed: 16 12 2022
medline: 17 2 2023
entrez: 15 12 2022
Statut: ppublish

Résumé

Gastrulation is a stage in embryo development where three germ layers arise to dictate the human body plan. In vitro models of gastrulation have been demonstrated by treating pluripotent stem cells with soluble morphogens to trigger differentiation. However, in vivo gastrulation is a multistage process coordinated through feedback between soluble gradients and biophysical forces, with the multipotent epiblast transforming to the primitive streak followed by germ layer segregation. Here, the authors show how constraining pluripotent stem cells to hydrogel islands triggers morphogenesis that mirrors the stages preceding in vivo gastrulation, without the need for exogenous supplements. Within hours of initial seeding, cells display a contractile phenotype at the boundary, which leads to enhanced proliferation, yes-associated protein (YAP) translocation, epithelial to mesenchymal transition, and emergence of SRY-box transcription factor 17 (SOX17)

Identifiants

pubmed: 36519269
doi: 10.1002/advs.202203614
pmc: PMC9929265
doi:

Substances chimiques

YAP-Signaling Proteins 0
SOX17 protein, human 0
SOXF Transcription Factors 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2203614

Subventions

Organisme : Australian Research Council
ID : FT180100417
Organisme : National Health and Medical Research Council
ID : APP1185021
Organisme : NCI NIH HHS
Pays : United States
Organisme : NIH HHS
ID : R01CA251443
Pays : United States
Organisme : NIH HHS
ID : R01CA251443
Pays : United States

Informations de copyright

© 2022 The Authors. Advanced Science published by Wiley-VCH GmbH.

Références

Nat Methods. 2014 Aug;11(8):847-54
pubmed: 24973948
Adv Sci (Weinh). 2023 Feb;10(5):e2203614
pubmed: 36519269
Cell Stem Cell. 2011 Apr 8;8(4):363-9
pubmed: 21474100
Adv Biol (Weinh). 2021 Jun;5(6):e2000525
pubmed: 33754491
Cancer Microenviron. 2012 Apr;5(1):29-38
pubmed: 21748438
Mech Dev. 1997 Nov;68(1-2):3-25
pubmed: 9431800
Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6364-9
pubmed: 20308546
Biophys J. 2020 May 5;118(9):2086-2102
pubmed: 31699335
Sci Rep. 2020 Jun 16;10(1):9695
pubmed: 32546756
Dev Dyn. 2012 Feb;241(2):270-83
pubmed: 22170865
Proc Natl Acad Sci U S A. 2006 Nov 7;103(45):16806-11
pubmed: 17077151
Dev Growth Differ. 2018 Oct;60(8):463-472
pubmed: 30368783
Stem Cell Reports. 2018 Dec 11;11(6):1357-1364
pubmed: 30449705
Proc Natl Acad Sci U S A. 2018 Aug 7;115(32):8167-8172
pubmed: 30038020
Dev Cell. 2020 Dec 21;55(6):679-694.e11
pubmed: 33207224
Dev Biol. 2008 Aug 15;320(2):391-401
pubmed: 18602094
EMBO J. 2013 Apr 3;32(7):938-53
pubmed: 23474895
Nat Protoc. 2016 Nov;11(11):2223-2232
pubmed: 27735934
Cell Stem Cell. 2008 Aug 7;3(2):182-95
pubmed: 18682240
Development. 2008 Nov;135(22):3719-29
pubmed: 18927149
ACS Med Chem Lett. 2014 Jul 14;5(9):993-8
pubmed: 25221655
Development. 2017 Jun 1;144(11):1923-1925
pubmed: 28559237
Dev Cell. 2019 Mar 25;48(6):751-763
pubmed: 30913407
Development. 2016 Feb 15;143(4):715-27
pubmed: 26884399
Genes Dev. 2010 Jun 1;24(11):1106-18
pubmed: 20516196
Cell Stem Cell. 2014 Feb 6;14(2):237-52
pubmed: 24412311
Development. 2019 Mar 25;146(6):
pubmed: 30814117
Semin Cell Dev Biol. 2009 Oct;20(8):986-97
pubmed: 19761865
Nature. 2007 Oct 25;449(7165):1049-52
pubmed: 17928866
Sci Rep. 2016 May 24;6:26562
pubmed: 27217206
Sci Rep. 2015 Jul 31;5:12617
pubmed: 26227093
Ciba Found Symp. 1992;165:27-41; discussion 42-9
pubmed: 1516473
Mol Aspects Med. 2013 Oct;34(5):1024-42
pubmed: 22921800
Cell Stem Cell. 2011 Mar 4;8(3):335-46
pubmed: 21362573
Development. 2015 Jun 15;142(12):2121-35
pubmed: 26015544
Cell. 2006 Aug 25;126(4):677-89
pubmed: 16923388
Gynecol Oncol. 2014 Aug;134(2):338-45
pubmed: 24924122
Cell Death Differ. 2021 Apr;28(4):1193-1207
pubmed: 33116297
Dev Biol. 2005 Dec 15;288(2):363-71
pubmed: 16289026
Nat Cell Biol. 2000 Feb;2(2):76-83
pubmed: 10655586
Development. 2018 Sep 21;145(18):
pubmed: 30115626
Nature. 2018 Jun;558(7708):132-135
pubmed: 29795348
Elife. 2017 Aug 10;6:
pubmed: 28826499
Dev Growth Differ. 2008 Dec;50(9):755-66
pubmed: 19046163
Semin Cell Dev Biol. 2002 Jun;13(3):251-60
pubmed: 12137734
Dev Suppl. 1992;:157-65
pubmed: 1299362
Adv Sci (Weinh). 2021 Jan 06;8(5):2001100
pubmed: 33717833
Science. 2013 Aug 30;341(6149):1240104
pubmed: 23990565
Tissue Eng Regen Med. 2021 Apr;18(2):199-215
pubmed: 33230800
Biomaterials. 2013 Nov;34(33):8140-8
pubmed: 23932245
Dev Dyn. 2011 Aug;240(8):1905-16
pubmed: 21761476
Gene Expr Patterns. 2007 Apr;7(5):558-73
pubmed: 17331809
Nat Commun. 2014;5:3070
pubmed: 24401905
Genes Dev. 2010 Feb 1;24(3):312-26
pubmed: 20123909
Stem Cell Reports. 2022 Feb 8;17(2):211-220
pubmed: 35063126
Nat Commun. 2012;3:1070
pubmed: 22990866
Nat Genet. 1999 Aug;22(4):361-5
pubmed: 10431240
J Tissue Eng Regen Med. 2015 Jan;9(1):1-12
pubmed: 23008262
Proc Natl Acad Sci U S A. 2010 Mar 16;107(11):4872-7
pubmed: 20194780
Nat Mater. 2018 Jul;17(7):633-641
pubmed: 29784997
Dev Cell. 2013 Oct 28;27(2):131-144
pubmed: 24176640
Development. 2012 Oct;139(19):3471-86
pubmed: 22949611
Nat Commun. 2015 Jul 14;6:7413
pubmed: 26172574
Histochem Cell Biol. 2010 May;133(5):595-606
pubmed: 20369364
J Cell Sci. 2012 Dec 15;125(Pt 24):5974-83
pubmed: 23097048
Stem Cell Reports. 2021 May 11;16(5):1039-1050
pubmed: 33979592
Nat Cell Biol. 2015 Apr;17(4):397-408
pubmed: 25812521

Auteurs

Pallavi Srivastava (P)

School of Chemistry, Australian Centre for NanoMedicine, University of New South Wales, Sydney, NSW, 2052, Australia.
School of Biomedical Sciences, University of New South Wales, Sydney, NSW, 2052, Australia.
Adult Cancer Program, School of Clinical Medicine, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW, 2052, Australia.

Sara Romanazzo (S)

School of Chemistry, Australian Centre for NanoMedicine, University of New South Wales, Sydney, NSW, 2052, Australia.

Chantal Kopecky (C)

School of Chemistry, Australian Centre for NanoMedicine, University of New South Wales, Sydney, NSW, 2052, Australia.
Adult Cancer Program, School of Clinical Medicine, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW, 2052, Australia.

Stephanie Nemec (S)

School of Materials Science and Engineering, University of New South Wales, Sydney, NSW, 2052, Australia.

Jake Ireland (J)

School of Chemistry, Australian Centre for NanoMedicine, University of New South Wales, Sydney, NSW, 2052, Australia.

Thomas G Molley (TG)

School of Materials Science and Engineering, University of New South Wales, Sydney, NSW, 2052, Australia.

Kang Lin (K)

School of Materials Science and Engineering, University of New South Wales, Sydney, NSW, 2052, Australia.

Pavithra B Jayathilaka (PB)

School of Chemistry, Australian Centre for NanoMedicine, University of New South Wales, Sydney, NSW, 2052, Australia.

Elvis Pandzic (E)

Katharina Gaus Light Microscopy Facility, Mark Wainwright Analytical Centre, University of New South Wales, Sydney, NSW, 2052, Australia.

Avani Yeola (A)

Adult Cancer Program, School of Clinical Medicine, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW, 2052, Australia.

Vashe Chandrakanthan (V)

School of Biomedical Sciences, University of New South Wales, Sydney, NSW, 2052, Australia.
Adult Cancer Program, School of Clinical Medicine, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW, 2052, Australia.

John Pimanda (J)

School of Biomedical Sciences, University of New South Wales, Sydney, NSW, 2052, Australia.
Adult Cancer Program, School of Clinical Medicine, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW, 2052, Australia.
Department of Haematology, Prince of Wales Hospital, Randwick, NSW, 2031, Australia.

Kristopher Kilian (K)

School of Chemistry, Australian Centre for NanoMedicine, University of New South Wales, Sydney, NSW, 2052, Australia.
Adult Cancer Program, School of Clinical Medicine, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW, 2052, Australia.
School of Materials Science and Engineering, University of New South Wales, Sydney, NSW, 2052, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH